Patents Expiring in December 2044
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avyxa Holdings | VYKOURA | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 220406-001 | Feb 3, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ||||
| Avyxa Holdings | VYKOURA | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 220406-002 | Feb 3, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ||||
| Avyxa Holdings | VYKOURA | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 220406-003 | Feb 3, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
